This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Singlera Genomics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Rui Liu and Cancer Assessment Innovation.
Introduction
Rui Liu is an inventor based in La Jolla, California, whose patent work concerns methods for assessing cancer and neoplasia. He is associated with Singlera Genomics, Inc.
Latest Patents
Liu is credited with 1 patent: “Compositions and Methods for Cancer and Neoplasia Assessment.” The patent describes compositions, kits, devices, systems, and methods for evaluating cancer or neoplasia in a subject. In particular, it covers assessment based on the methylation status of selected target polynucleotide sequences, including genomic DNA sequences.
Career Highlights
Liu’s listed patent highlights work on molecular approaches to cancer assessment. His association with Singlera Genomics, Inc. connects this invention to a company working in genomics.
Collaborations
The provided information lists Athurva J. Gore and Jeffrey A. Gole as Liu’s coworkers. Their names appear alongside his work in the cancer-assessment patent context.
Conclusion
Rui Liu’s patent focuses on using DNA methylation analysis to support the assessment of cancer and neoplasia.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile